Literature DB >> 15921860

Etiology of sporadic Alzheimer's disease: somatostatin, neprilysin, and amyloid beta peptide.

E Hama1, T C Saido.   

Abstract

We recently demonstrated that amyloid beta peptide (Abeta) is catabolized primarily by a neutral endopeptidase, neprilysin, in the brain and that a neuropeptide, somatostatin (SST), regulates brain Abeta level via modulation of neprilysin activity. Because SST expression in the brain declines upon aging in various mammals including rodents, apes and humans, we hypothesize that the aging-dependent reduction of SST triggers accumulation of Abeta in the brain by suppressing neprilysin action. This hypothesis accounts for the fact that aging is the predominant risk factor for Sporadic Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15921860     DOI: 10.1016/j.mehy.2005.02.045

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  14 in total

Review 1.  β-Amyloid peptides and amyloid plaques in Alzheimer's disease.

Authors:  Gunnar K Gouras; Tomas T Olsson; Oskar Hansson
Journal:  Neurotherapeutics       Date:  2015-01       Impact factor: 7.620

2.  Neprilysin gene expression requires binding of the amyloid precursor protein intracellular domain to its promoter: implications for Alzheimer disease.

Authors:  Nikolai D Belyaev; Natalia N Nalivaeva; Natalia Z Makova; Anthony J Turner
Journal:  EMBO Rep       Date:  2008-12-05       Impact factor: 8.807

3.  Effect of sodium valproate administration on brain neprilysin expression and memory in rats.

Authors:  Natalia N Nalivaeva; Nikolai D Belyaev; David I Lewis; Alasdair R Pickles; Natalia Z Makova; Daria I Bagrova; Nadezhda M Dubrovskaya; Svetlana A Plesneva; Igor A Zhuravin; Anthony J Turner
Journal:  J Mol Neurosci       Date:  2011-09-20       Impact factor: 3.444

4.  The Alzheimer's amyloid-degrading peptidase, neprilysin: can we control it?

Authors:  N N Nalivaeva; N D Belyaev; I A Zhuravin; A J Turner
Journal:  Int J Alzheimers Dis       Date:  2012-07-26

5.  Hypoxia-induced down-regulation of neprilysin by histone modification in mouse primary cortical and hippocampal neurons.

Authors:  Zheng Wang; Dehua Yang; Xiaojie Zhang; Ting Li; Jia Li; Yu Tang; Weidong Le
Journal:  PLoS One       Date:  2011-04-29       Impact factor: 3.240

Review 6.  Metabolism of amyloid β peptide and pathogenesis of Alzheimer's disease.

Authors:  Takaomi C Saido
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2013       Impact factor: 3.493

Review 7.  Neprilysin and Aβ Clearance: Impact of the APP Intracellular Domain in NEP Regulation and Implications in Alzheimer's Disease.

Authors:  Marcus O W Grimm; Janine Mett; Christoph P Stahlmann; Viola J Haupenthal; Valerie C Zimmer; Tobias Hartmann
Journal:  Front Aging Neurosci       Date:  2013-12-23       Impact factor: 5.750

8.  Neurogenesis, Neurodegeneration, Interneuron Vulnerability, and Amyloid-β in the Olfactory Bulb of APP/PS1 Mouse Model of Alzheimer's Disease.

Authors:  Carlos De la Rosa-Prieto; Daniel Saiz-Sanchez; Isabel Ubeda-Banon; Alicia Flores-Cuadrado; Alino Martinez-Marcos
Journal:  Front Neurosci       Date:  2016-05-30       Impact factor: 4.677

9.  Impact of intrauterine hypoxia on adolescent and adult cognitive function in rat offspring: sexual differences and the effects of spermidine intervention.

Authors:  Meng Mao; Lin Yang; Zhuo Jin; Ling-Xu Li; Yan-Ru Wang; Ting-Ting Li; Ya-Jun Zhao; Jing Ai
Journal:  Acta Pharmacol Sin       Date:  2020-07-21       Impact factor: 6.150

10.  Orexin receptors exert a neuroprotective effect in Alzheimer's disease (AD) via heterodimerization with GPR103.

Authors:  Julie Davies; Jing Chen; Ryan Pink; David Carter; Nigel Saunders; Georgios Sotiriadis; Bo Bai; Yanyou Pan; David Howlett; Annette Payne; Harpal Randeva; Emmanouil Karteris
Journal:  Sci Rep       Date:  2015-07-30       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.